palbociclib 75 MG Oral Tablet

RxCUI
2284107
RxNorm name
palbociclib 75 MG Oral Tablet
Display name
palbociclib 75 MG Oral Tablet
Full name
palbociclib 75 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IbrancePALBOCICLIBU.S. Pharmaceuticals89a142d5-7e61-48bf-9e77-e2cd124c47922026-07-06Warnings, Adverse reactionsExact identifier
rxcui: 2284107
IbrancePALBOCICLIBPfizer Laboratories Div Pfizer Incfecbdd7d-b729-41b5-9872-231b8fe104ce2026-07-02Warnings, Adverse reactionsExact identifier
rxcui: 2284107

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fecbdd7d-b729-41b5-9872-231b8fe104cepalbociclib 75 MG Oral TabletPSN12These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260225
fecbdd7d-b729-41b5-9872-231b8fe104cepalbociclib 75 MG Oral TabletSCD12These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260225
89a142d5-7e61-48bf-9e77-e2cd124c4792palbociclib 75 MG Oral TabletSCD10These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260530
89a142d5-7e61-48bf-9e77-e2cd124c4792palbociclib 75 MG Oral TabletPSN10These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) tablets, for oral use Initial U.S. Approval: 201520260530